Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-β receptor I in head and neck cancer
Head & Neck Aug 30, 2017
Fanelli MF, et al. – The researchers explored the role of circulating tumor microemboli (CTM) in progression–free survival (PFS) in head and neck squamous cell carcinoma (HNSCC). Investigations suggested that CTM1/2, TGF–β receptor I (TGF–βRI) expression and unfavorable CTM kinetics might represent poor prognosis in locally advanced HNSCC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
